No Detail Found!

Identification of Glycolysis-Related Gene Signature and Prediction on Prognosis of Colon Cancer

Author(s)
Qingsen Ran Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Science, Beijing 100700, China; Postdoctoral Research Station, China Academy of Chinese Medical Science, Beijing 100700, China
Manjing Li nstitute of Chinese Materia Medica, China Academy of Chinese Medical Science, Beijing 100700, China
Jiayin Han nstitute of Chinese Materia Medica, China Academy of Chinese Medical Science, Beijing 100700, China
Lifang Wang nstitute of Chinese Materia Medica, China Academy of Chinese Medical Science, Beijing 100700, China
Han Wang nstitute of Chinese Materia Medica, China Academy of Chinese Medical Science, Beijing 100700, China; Affiliated Hospital of Changchun University of Chinese Medicine, Changchun 130021, China
Shaobo Liu The Key Laboratory of Optimal Utilization of Natural Medicine Resources, School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang 550025, China
Yanping Wang Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Science, Beijing 100700, China
Abstract
Identification of core biomarkers for cancer prevention and treatment is crucial. Tumor glycolysis is an important metabolic phenotype and many natural compounds from medicinal plants exhibit antiglycation effects. Therefore, it is of potential significant to find biomarkers based on glycolysis-related genes in predicting the prognosis of colon cancer (CC), a common invasive gastrointestinal tumor. In this study, clinical and gene data were collected to identify glycolytic genes that significantly associated with overall survival (OS) rate of CC patients through gene set enrichment analysis (GSEA) and Cox regression models. The K-M method was used to determine the difference of OS rate with high and low risk scores. The accuracy of risk scores were determined based on receiver operating characteristic (ROC) curve. Hierarchical analysis and Cox regression were performed to assess the correlation between CC risk score and clinical symptoms. Moreover, qPCR was used to verify the expression level of prognostic genes in human colorectal cancer cell line (HCT116) and human colorectal epithelial cells (FHC cells). The results showed 202 glycolytic genes were found with statistical differences, and 4 glycolytic genes were identified, including Enolase 3 (ENO3), glypican-1 (GPC1), Nucleolar Protein 3 (NOL3) and Stanniocalcin 2 (STC2). A prognostic risk score model was established, and the OS rate of high-risk patients was found significantly reduced (p <0.001) compared to low-risk patients. The 5-year OS ROC area under curve (AUC) of the model was 0.75. qPCR results confirmed that glycolysis-related genes ENO3, GPC1, NOL3 and STC2 were significantly upregulated in HCT116 cells compared to FHC cells. In conclusion, our study identified four glycolytic genes that significant impact prognosis of CC, and established a prognostic risk prediction model, which can provide reference for prognosis assessment and efficient treatment in CC.
Publication Details
Page(s) 263-272
Published Journal: Pakistan Journal of Zoology, Volume: 56, Issue: 1, Year: 2024

Request the full text from PASTIC

Keywords
Colon cancer, Biomarkers, Glycolysis, Metabolic signature, Risk score model, Prognosis Judgment
0

Citations

0

Downloads

50

Views